| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 58,749 | 62,829 | 64,002 | 52,200 | | Cost of Revenue | 46,441 | 49,446 | 49,416 | 40,262 | | | Gross Profit | 12,308 | 13,383 | 14,586 | 11,938 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,827 | 7,939 | 8,473 | 8,414 | | Non Recurring | (362) |
-
| 362 | 2,303 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,843 | 5,444 | 5,751 | 1,221 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3) | 17 | (41) | 15 | | Earnings Before Interest And Taxes | 3,562 | 5,461 | 5,710 | 1,236 | | Interest Expense | (835) | 413 | 422 | 449 | | Income Before Tax | 4,397 | 5,048 | 5,288 | 787 | | Income Tax Expense | 1,609 | 1,839 | 1,934 | 202 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,788 | 3,209 | 3,354 | 585 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,788 | 3,209 | 3,354 | 585 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,788 | $3,209 | $3,354 | $585 |
|
0.01% Nasdaq 
Income Statement
